[Overall meta-analysis indicated that the -160A allele carriers (CA+AA) had a 21% elevated risk of prostate cancer, when compared with the homozygotes (CC) (OR = 1.21; 95% CI: 0.97-1.51; P = 0.090, Pheterogeneity = 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE